INTRODUCTION
============

Septins are a family of heteropolymeric filament-forming guanine nucleotide-binding proteins originally discovered in a screen for genes involved in cell division of budding yeast ([@B19]). Subsequent studies identified septins in most eukaryotic organisms, with the exception of plants ([@B33]; [@B46]; [@B44]). Septins have been implicated in several cellular functions such as cell cycle control, cytokinesis, mitotic spindle formation, and plasma membrane compartmentalization ([@B38]; [@B13]; [@B65]; [@B4]). The accumulating biochemical and cell biological observations in lower eukaryotic septins suggest that they may function through the assembly of diffusion barriers ([@B64]; [@B10]) or as scaffolds ([@B37]; [@B57]).

In mammals, 14 septin genes have been identified. Recent studies reported abundant expression of septins in neuronal tissues ([@B32]; [@B27]). Several septins are found to accumulate in postsynaptic density fractions of brain, by mass spectrometry analyses ([@B48]; [@B6]). These septins are suggested to be involved in dendritic maturation, including spine morphogenesis and synaptic connectivity in cultured hippocampal neurons ([@B62]; [@B67]; [@B36]). The physiological functions of septins in neurons, however, still remain largely unknown.

The coordinated migration of neurons is essential for functional and architectural formation of mammalian brain. During corticogenesis, postmitotic neurons generated in the ventricular zone (VZ) move through the intermediate zone (IZ) and arrive at the superficial layers of the cortical plate (CP) ([@B51]; [@B16]; [@B20]). Disturbance of this migration process can cause misplacement of neurons and result in disorganized cortical lamination, a defect observed in neurological disorders such as mental retardation and epilepsy ([@B5]). Analyses based on the human and mouse genetics have suggested the implication of several genes, such as *Reelin*, *LIS1*, *DCX*, and *CDK5*, in neuronal migration ([@B17]; [@B47]). Such simple genetic approaches, however, seem not to be sufficient for the elucidation of molecular mechanisms underlying cortical development, because mutations in genes potentially involved in corticogenesis may cause severe abnormality in earlier developmental events, thereby result in lethality before cortical development. In utero electroporation method ([@B25]; [@B52]; [@B60]) is a promising solution for the problem. This method allows us to perform acute expression or knockdown of genes of interest in neuronal precursor cells in embryonic cerebral cortex, followed by observation of the cell shape, migration and proliferation of transfected neurons in subsequent developmental stages.

In the present study, by using this approach, we examined the function of Septin 14 (Sept14), a member of septin family molecules abundantly expressed in developing cerebral cortex, in neuronal development. We show that Sept14 is involved in neuronal migration through the interaction with Sept4. Furthermore, we identify a role of Sept14 and Sept4 in the formation of neuronal process.

MATERIALS AND METHODS
=====================

Plasmids
--------

cDNA encoding mouse Sept14 and Sept3 was obtained by polymerase chain reaction (PCR) from mouse brain cDNA library. The cDNA encoding Sept14 full (amino acids \[aa\] 1-467), Sept14ΔCC (aa 1-366), Sept14CC (aa 367-467), Sept4, or Sept3 was inserted into pCAG-FLAG-MCS2 or pCAG-myc-MCS2, modified vectors of pCAG-MCS2 ([@B29]). Enhanced green fluorescent protein (EGFP)-expression vector pGAG-EGFP was kindly provided by Drs. Hoshino (National Institute of Neuroscience, Tokyo, Japan) and Kawauchi (Keio University, Tokyo, Japan). cDNA encoding mouse Sept4 was kindly provided by Dr. Kinoshita (Nagoya University, Nagoya, Japan).

Primary Antibodies
------------------

Antibodies against green fluorescent protein (GFP) (rabbit polyclonal; MBL, Aichi, Japan; rat monoclonal, Nakarai, Kyoto, Japan), NeuN (mouse monoclonal; Millipore Bioscience Research Reagents, Temecula, CA), Nestin (mouse monoclonal; BD Biosciences, Franklin Lakes, NJ), tau-1 (mouse monoclonal; Millipore Bioscience Research Reagents), β III-tubulin (mouse monoclonal; Millipore Bioscience Research Reagents), microtubule-associated protein 2 (mouse monoclonal; Sigma-Aldrich, St. Louis, MO), β-tubulin (mouse monoclonal; Sigma-Aldrich), 5-bromo-2-deoxyuridine (BrdU, mouse monoclonal; Sigma-Aldrich), myc (mouse monoclonal; Santa Cruz Biotechnology, Santa Cruz, CA), and FLAG (mouse monoclonal and rabbit polyclonal; Sigma-Aldrich) were purchased. Rabbit polyclonal antibodies against Sept6, Sept7, and Sept11 were prepared as described previously ([@B18]; [@B42]; [@B27]). We generated a rabbit polyclonal antibody against mouse Sept14 by using maltose-binding protein-fused C-terminal region (aa 321-467) expressed in Escherichia coli as an antigen. Rabbit polyclonal antibodies against Sept3 and Sept4 were kindly provided by Drs. M. Takehashi (Osaka Ohtani University, Osaka, Japan) and M. Kinoshita (Nagoya University), respectively.

Small Interfering RNAs (siRNAs)
-------------------------------

25mer siRNA duplexes (Stealth RNAi; Invitrogen, Carlsbad, CA) were designed to target two distinct regions in the *Sept14* coding sequence (Sept14-siRNA\#1, 5′-CCTACAGAGGTTCAAGAACAACATA-3′; Sept14-siRNA\#2, 5′-GAGGAGGTCAAAGTTGGAAAGAGAA-3′), two distinct regions in the *Sept4* coding sequence (Sept4-siRNA\#1, 5′-CGGATCATGCAAACCGTGGAGATTA-3′; Sept4-siRNA\#2, 5′-AGCGGGTCAACATTGTGCCTATCTT-3′), and one region in the *Sept3* coding sequence (Sept3-siRNA, 5′-CCCTGGAGGAGAAGTCGGAATTCAA-3′). Stealth RNA interference (RNAi) Negative Control Medium GC Duplex \#2 (Invitrogen) was used as a negative control. To generate an RNAi-resistant mutant of Sept14 (Sept14^R^) and Sept14ΔCC (Sept14ΔCC^R^), we introduced four silent mutations, as underlined, in the target sequence of Sept14-siRNA\#1 (5′-CCT[T]{.ul}CA[A]{.ul}AGGTT[T]{.ul}AAGAACAA[T]{.ul}ATA-3′). To generate an RNAi-resistant mutant of Sept4 (Sept4^R^), three silent mutations are introduced in the target sequence of Sept4-siRNA\#1 (5′-CGGAT[G]{.ul}ATGCA[G]{.ul}AC[A]{.ul}GTGGAGATTA-3′).

In Utero Electroporation
------------------------

All animal experiments were performed according to the guidance of the Institute for Developmental Research. Pregnant ICR mice were purchased from SLC Japan (Sizuoka, Japan). In utero electroporation was performed as described previously ([@B60]), with some modifications. In brief, 2 μl of nucleotide solution containing expression plasmid (2 μg) and siRNA (20 pmol) was introduced into lateral ventricles of embryos, followed by electroporation using CUY21 electroporator (NEPA Gene, Chiba, Japan) with 50 ms of 30-V electronic pulse for 6 times with 950-ms intervals. All electroporations in this report were performed on embryonic day 14.5 (E14.5).

Immunohistochemistry
--------------------

The developing brains fixed with 4% paraformaldehyde (PFA) were sectioned coronally with Vibratome (Leica, Wetzlar, Germany) at 100 μm for E13.5 and E15.5, 70 μm for E17.5 and postnatal day 2 (P2), and 50 μm for P10. The slices were treated with phosphate-buffered saline (PBS) containing 2% goat serum and 0.5% Triton X-100 for 1 h, and subsequently incubated with diluted primary antibodies in PBS at 4°C overnight. After several washes with PBS, slices were treated with Alexa488- or Alexa568-conjugated secondary antibodies diluted in PBS for 1 h at 4°C. In some experiment, nuclei were visualized by 4′,6-diamino-2-phenylindole (DAPI) (Nakarai). Fluorescent images were obtained by laser scanning confocal microscopy (FV1000; Olympus, Tokyo, Japan).

BrdU Incorporation Experiment
-----------------------------

Embryos were electroporated in utero at E14.5. 30 h after electroporation. Pregnant mice were given two intraperitoneal injections of BrdU at 50 mg/kg body weight, with a 30-min interval. 1 h after the first injection, embryonic brains were fixed. Vibratome sections were immunostained with anti-GFP and Alexa488-conjugated secondary antibody. After being briefly fixed with 4% PFA, sections were treated with 2 N HCl for 30 min at 37°C followed by the immunostaining with anti-BrdU and Alexa568-conjugated secondary antibody.

Quantitative Estimation of Neuronal Migration and Leading Process Formation
---------------------------------------------------------------------------

The distribution of EGFP-positive or EGFP/FLAG double-positive cells in brain slices was quantified as follows. The coronal sections of cerebral cortices containing the labeled cells were classified into four regions, layer II--IV, V--VI, IZ, and the subventricular zone (SVZ)/VZ, as described previously ([@B28]). The number of labeled cells in each region of at least four slices per brain was calculated. To measure the length of leading process of migrating neurons, images of EGFP-positive neurons in the lower CP were acquired by laser scanning confocal microscopy. Postmigratory neurons in the superficial CP were excluded from the assay. At least seven independent brains were electroporated and analyzed for each experiment.

Primary Culture and Immunocytochemistry
---------------------------------------

Primary culture of mouse cortical and hippocampal neurons was performed as described previously ([@B30]; [@B55]). In some experiments, cerebral cortices electroporated at E14.5 were dissociated at E17.5 and cultured. Transfection into primary cultured neurons was performed by Nucleofector (Amaxa Biosystems, Cologne, Germany), according to the manufacturer\'s protocol. Neurons were fixed with 3.7% formaldehyde in PBS for 10 min and treated with PBS containing 0.05% Triton X-100 for 10 min. Neurons were incubated with primary antibodies overnight at 4°C, washed, and incubated for 1 h with secondary antibodies. Fluorescent images were obtained by laser scanning confocal microscopy.

Preparation of Various Mouse Tissues
------------------------------------

Various tissues and brain regions were dissected from adult ICR mice. Cytosol and membrane extracts of tissues were prepared as described previously ([@B26]). To analyze the developmental expression profiles of septins, whole extracts of cerebral cortices of embryonic and postnatal mice were prepared with 3 volumes of buffer L (20 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 10 μg/ml leupeptin, and 10 μM phenylmethylsulfonyl fluoride, pH 7.4) and subjected to SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblotting. Concentrations of protein were calculated with bicinchoninic acid protein assay kit (Pierce Chemical, Rockford, IL).

Reverse Transcription (RT)-PCR
------------------------------

Total RNA was isolated from cerebral cortex of E13.5 or P0 mice by ISOGEN RNA extraction kit (Nippon Gene, Tokyo, Japan). PCR primers were designed as follows: 5′-AGGCCGGTGCTGAGTATGTC-3′ and 5′-TGCCTGCTTCACCACCTTCT-3′ for mouse *GAPDH* and 5′-TCGCTTTCAAAGAACGACCT-3′ and 5′-AAACTCCCCAAGGGTAATGG-3′ for mouse *Sept14*. RT-PCR was performed with SuperScript one-step RT-PCR kit (Invitrogen) according to the manufacturer\'s protocol.

Yeast Two-Hybrid Analysis
-------------------------

pYTH9-mouse Sept14 was used as a bait in the two-hybrid screen with human brain cDNA library fused to pACT2 (BD Biosciences), following the Matchmaker two-hybrid system protocol (Clontech, Mountain View, CA). Subsequent two-hybrid interaction analyses were carried out as described previously ([@B40]).

Immunoprecipitation Analyses
----------------------------

COS7 cells were transfected with Lipofectamine (Invitrogen), according to the manufacturer\'s protocol. Transfected COS7 cells were lysed with buffer L. Cell lysates were incubated with anti-FLAG or anti-myc for 45 min at 4°C, followed by additional incubation for 45 min with protein A-Sepharose (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom). The beads were washed three times with buffer L, and the bound proteins were subjected to SDS-PAGE and immunoblotting. For the precipitation of endogenous Sept14, control immunoglobulin (Ig)G, or anti-Sept14 was cross-linked to protein A-Sepharose beads by BS3 (Thermo Fisher Scientific, Waltman, MA) according to the manufacturer\'s protocol. Whole extract of cerebral cortices from P2 mice was prepared with 3 volumes of buffer L and then incubated with the cross-linked beads for 45 min at 4°C. Bound proteins were eluted with SDS sample buffer and analyzed by immunoblotting.

RESULTS
=======

Distribution of Sept14 in Mouse Tissues
---------------------------------------

To elucidate biological functions of Sept14, we generated a polyclonal antibody against Sept14 and examined the Sept14-expression profile in adult mouse tissues. Immunoblot analyses revealed strong cytosolic expression of Sept14 in brain, including cerebrum, hippocampus and cerebellum, and testis ([Figure 1](#F1){ref-type="fig"}A). We next examined the expression profile of Sept14 during cerebral cortex development. Although Sept14 was not detected at E13.5 ([Figure 1](#F1){ref-type="fig"}B), it was visualized around E15.5 and then dramatically increased and reached the maximal level around E17.5 ([Figure 1](#F1){ref-type="fig"}B). RT-PCR analyses of *Sept14* transcription supported its developmental expression in cerebral cortex ([Figure 1](#F1){ref-type="fig"}C). We also examined the expression of Sept14 in embryonic cerebral cortex by immunohistochemistry. Little immunoreactivity was observed in E13.5 cortex (data not shown), which was consistent with the result of immunoblot analyses ([Figure 1](#F1){ref-type="fig"}B). In E15.5 cortex, Sept14 was observed predominantly in upper IZ and CP, but very weakly in SVZ and VZ ([Figure 1](#F1){ref-type="fig"}D). Considering that CP and IZ at this developmental stage contain migrating neurons, these results suggest a possibility that Sept14 is involved in the radial neuronal migration during corticogenesis.

![Expression profile of Sept14. (A) Cytosolic (20 μg protein/lane) and membrane (30 μg protein/lane) fractions from adult mice organs were separated by SDS-PAGE and subjected to immunoblotting with anti-Sept14 or anti-Sept3. EDL, extensor degitorum longus muscle; SOL, soleus muscle. (B) Whole lysates of cerebral cortices at various developmental stages (50 μg protein/lane) were subjected to SDS-PAGE and immunoblotting with antibodies against indicated proteins. (C) RT-PCR was performed to amplify *Sept14*- or *GAPDH*-specific product from total RNA isolated from cerebral cortex of E13.5 or P0 mice. (D) Coronal section of E15.5 mouse cerebral cortex was immunostained with anti-Sept14 (green) and anti-Nestin (red). Bar,100 μm.](zmk0081094200001){#F1}

Roles of Sept14 in Neuronal Migration
-------------------------------------

To investigate the function of Sept14 in neuronal migration, we sought to decrease the expression of Sept14 by RNAi with in utero electroporation. We designed two siRNAs, Sept14-siRNA\#1 and Sept14-siRNA\#2, against distinct regions of mouse *Sept14* coding sequence. Both siRNAs effectively knocked down the expression of myc-Sept14 in COS7 cells ([Figure 2](#F2){ref-type="fig"}A). We next transfected these siRNAs into dissociated cortical neurons and cultured for 3 d. Immunoblot analysis revealed that both Sept14-siRNA\#1 and Sept14-siRNA\#2 significantly decreased the amount of endogenous Sept14 ([Figure 2](#F2){ref-type="fig"}B). Knockdown of Sept14 was also confirmed by immunocytochemistry in cortical neurons (Supplemental Figure 1). To examine the possible function of Sept14 in neuronal migration, siRNAs and pCAG-EGFP were coelectroporated into VZ cells at E14.5. The animals were killed at P2 to observe the localization of transfected cells and their progeny. Most control siRNA-transfected neurons normally migrated to the superficial layers of the cortical plate ([Figure 2](#F2){ref-type="fig"}, C and D). In contrast, a considerable portion of cells transfected with Sept14-siRNA\#1 or Sept14-siRNA\#2 remained in layer V to IV of CP and in IZ ([Figure 2](#F2){ref-type="fig"}, C and D). It should be noted that many Sept14-siRNAs-transfected neurons reached the superficial layer of CP ([Figure 2](#F2){ref-type="fig"}B), possibly attributable to the limited RNAi effect of these siRNAs. The defective positioning of Sept14-siRNAs--transfected neurons in the ventricular side of CP was still observed in the mice analyzed at P10 (Supplemental Figure 2; data not shown).

![Roles of Sept14 in neuronal migration. (A) pCAG-myc-Sept14 was cotransfected into COS7 cells with control siRNA, Sept14-siRNA\#1 or Sept14-siRNA\#2. After 72 h, cells were lysed and subjected to immunoblotting with anti-myc or anti-β-tubulin. (B) Cortical neurons were transfected with control siRNA, Sept14-siRNA\#1, or Sept14-siRNA\#2. After 72 h, cells were lysed and subjected to immunoblotting with anti-Sept14 or anti-β-tubulin. (C) pCAG-EGFP was coelectroporated with control siRNA, Sept14-siRNA\#1, or Sept14-siRNA\#2 into cerebral cortices at E14.5 and fixed at P2. Coronal sections were immunostained with anti-GFP (white). Nuclei were stained with DAPI (blue). Dotted lines represent pial and ventricular surfaces. Bars, 100 μm. II--IV, layers II--IV of CP; V--VI, layers V and VI of CP. (D) Quantification of the distribution of EGFP-positive cells in distinct parts of the cerebral cortex (layer II--IV, layer V--VI, IZ, and SVZ/VZ) for each condition shown in C. Error bars indicate SD. \*p \< 0.01, percentage of cells in each region relative to the corresponding values with control condition.](zmk0081094200002){#F2}

We next examined whether the observed mislocalization of neurons results from a possible effect of Sept14-siRNAs on neuronal proliferation. After pCAG-EGFP was electroporated into E14.5 embryos with control siRNA or Sept14-siRNA\#1, pregnant mice were subjected to intraperitoneal injection of BrdU at E15.5. Embryos were then killed 1 h after the injection to observe the BrdU incorporation. Consequently, the incorporation rate was not statistically different between control and Sept14-siRNA\#1--introduced cells ([Figure 3](#F3){ref-type="fig"}, A and B). Moreover, positioning of the BrdU/EGFP-double positive cells within VZ and SVZ was not affected by the transfection of Sept14-siRNA\#1([Figure 3](#F3){ref-type="fig"}A). Together with the result that the expression of Sept14 in cerebral cortex at E15.5 was limited in CP and upper IZ ([Figure 1](#F1){ref-type="fig"}D), neuronal positioning defect by Sept14-siRNAs is most likely to attribute to abnormality in cell migration rather than proliferation.

![Effect of Sept14-silencing on cell division in VZ. (A) E14.5 cortices were coelectroporated with pCAG-EGFP together with control siRNA or Sept14-siRNA\#1. BrdU incorporation was examined as described in *Materials and Methods*. Coronal sections of brains were immunostained by anti-GFP (green) and anti-BrdU (red). Arrowheads indicate BrdU/EGFP double-positive cells. Dotted lines represent ventricular surface. Bars, 50 μm. (B) Quantification of BrdU/EGFP double-positive cells among EGFP-positive cells. Error bars indicate SD.](zmk0081094200003){#F3}

Identification of Sept4 as a Sept14-binding Protein
---------------------------------------------------

To investigate the molecular basis of the function of Sept14 on neuronal migration, we attempted to identify binding partners for Sept14. We performed a yeast two-hybrid screen with Sept14 as a bait and a cDNA library from human brain. Subsequent DNA sequence analyses revealed that Sept4, another septin molecule specifically expressed in brain and testis ([@B31]; [@B23]) is a candidate binding partner for Sept14, as suggested recently ([@B50]).

We examined the expression profile of Sept4 in developing cerebral cortex. A constant expression of Sept4 was observed from E13.5 to P30 by immunoblotting ([Figure 4](#F4){ref-type="fig"}A). Immunohistochemistry revealed that the expression of Sept4 was predominantly observed in IZ and CP at E15.5 ([Figure 4](#F4){ref-type="fig"}B). To confirm the interaction between Sept14 and Sept4, immunoprecipitation analyses were performed using the COS7 cell expression system. Consequently, myc-Sept4 was coprecipitated with FLAG-Sept14 ([Figure 4](#F4){ref-type="fig"}C). In contrast, myc-Sept3, a brain-specific septin ([Figure 1](#F1){ref-type="fig"}A), did not associate with FLAG-Sept14 under the conditions used ([Figure 4](#F4){ref-type="fig"}C). We also examined the interaction of endogenous Sept14 with Sept4 by immunoprecipitation. When Sept14 was precipitated from mouse brain lysate, Sept4 was detected in the precipitate ([Figure 4](#F4){ref-type="fig"}D). Sept3, Sept6, Sept7, and Sept11, in contrast, did not coprecipitate with Sept14 under these conditions ([Figure 4](#F4){ref-type="fig"}D). These results suggest that Sept14 forms a complex with Sept4 in physiological conditions. We next tried to determine the binding region of Sept14 to Sept4. Because the C-terminal coiled-coil region in septin is important for the interaction with other septin molecules ([@B54]; [@B42]; [@B39]), we generated two Sept14 mutants, Sept14ΔCC and Sept14CC ([Figure 4](#F4){ref-type="fig"}E). Myc-Sept14ΔCC was not coprecipitated with FLAG-Sept4 under conditions in which wild-type Sept14 and Sept14CC associates with Sept4 ([Figure 4](#F4){ref-type="fig"}F). These results suggest that the C-terminal coiled-coil region of Sept14 is responsible for interaction with Sept4.

![Interaction of Sept14 with Sept4. (A) Whole lysates of mouse cerebral cortices at various developmental stages were subjected to SDS-PAGE and immunoblotting with anti-Sept4. (B) Coronal section of E15.5 mouse cerebral cortex was immunostained with anti-Sept4 (green) and anti-Nestin (red). Bar, 100 μm. (C) COS7 cells were cotransfected with FLAG-Sept14, myc-Sept4, and myc-Sept3 in the indicated combinations and cultured for 48 h. Cells were then lysed and subjected to immunoprecipitation with anti-FLAG. Cell lysates (lysate) and precipitated materials (IP: FLAG) were subjected to immunoblotting with anti-myc or anti-FLAG. (D) Lysate of mouse cerebral cortices were immunoprecipitated with anti-Sept14. Samples were then subjected to immunoblotting with anti-Sept14, -Sept4, -Sept3, -Sept6, -Sept7, or -Sept11. (E) Two deletion mutants of Sept14 used in this study are shown. CC, coiled-coil domain. (F) COS7 cells were cotransfected with FLAG-Sept4, myc-Sept14, myc-Sept14ΔCC, and myc-Sept14CC in the indicated combinations and cultured for 48 h. Cells were lysed and immunoprecipitated with anti-FLAG. Immunoblotting was done as described in C.](zmk0081094200004){#F4}

Involvement of Sept4 as Well as Sept14 in Neuronal Migration
------------------------------------------------------------

Because Sept4 is expressed in developing cortex and interacts with Sept14, we speculate that Sept4, as well as Sept14, is involved in neuronal migration in the cerebral cortex. To examine this possibility, we first designed two siRNA duplexes, Sept4-siRNA\#1 and Sept4-siRNA\#2, to target distinct regions in the *Sept4* coding sequence. Both siRNAs effectively knocked down the expression of myc-Sept4 in COS7 cells ([Figure 5](#F5){ref-type="fig"}A), and endogenous Sept4 in cortical neurons ([Figure 5](#F5){ref-type="fig"}B and Supplemental Figure 3). To examine whether Sept4 is involved in neuronal migration, siRNAs and pCAG-EGFP were coelectroporated into VZ cells at E14.5. When analyzed at P2, many Sept4-siRNA\#1-- or Sept4-siRNA\#2--transfected neurons were abnormally located in layer V to layer IV of CP and IZ ([Figure 5](#F5){ref-type="fig"}, C and D). This phenotype was very similar to that observed in Sept14-knockdown experiments ([Figure 2](#F2){ref-type="fig"}, C and D). These results strongly suggest that Sept4, as well as Sept14, is required for the proper positioning of cortical neurons during corticogenesis. It is notable that silencing of Sept3 did not affect the positioning of cortical neurons (Supplemental Figure 4). It seems that not all septins expressed in the developing brain are implicated in proper neuronal positioning.

![Functional role of Sept4 in neuronal migration. *A*, COS7 cells were cotransfected with pCAG-myc-Sept4 together with control siRNA, Sept4-siRNA\#1, or Sept4-siRNA\#2. After 72 h, cells were lysed and subjected to immunoblotting with anti-myc or anti-β-tubulin. (B) Cortical neurons were transfected with control siRNA, Sept4-siRNA\#1, or Sept4-siRNA\#2. After 72 h, cells were lysed and subjected to immunoblotting with anti-Sept4, anti-Sept14, or anti-β-tubulin. (C) pCAG-EGFP was coelectroporated with Sept4-siRNA\#1, Sept4-siRNA\#2, or Sept14-siRNA\#1 into cerebral cortices at E14.5, followed by fixation at P2. Coronal sections were prepared and immunostained with anti-GFP (white). Nuclei were stained with DAPI (blue). Dotted lines represent pial and ventricular surfaces. Bars, 100 μm. (D) Quantification of the distribution of EGFP-positive cells in distinct parts of the cerebral cortex (layer II--IV, layer V--VI, IZ, and SVZ/VZ) for each experimental condition shown on the right. Error bars indicate SD. \*p \< 0.01, percentage of cells in each region relative to the corresponding values with control condition.](zmk0081094200005){#F5}

We next examined whether the knockdown of Sept14 has a synergistic effect on Sept4 knockdown. To this end, both Sept4-siRNA\#1 and Sept14-siRNA\#1 were coelectroporated at E14.5 and observation was performed at P2. The distribution of cells transfected with both siRNAs, however, was not significantly different from that of each single knockdown ([Figures 2](#F2){ref-type="fig"}D and [5](#F5){ref-type="fig"}D). Thus, it is not likely that Sept14 and Sept4 synergistically function in neuronal migration, at least based on a loss-of-function assay.

As a next set of experiments, we performed rescue experiments on Sept14 knockdown. We generated vectors expressing siRNA-resistant form of Sept14 (Sept14^R^) and its truncated mutant (Sept14ΔCC^R^) that harbor four silent mutations within the sequence targeted by Sept14-siRNA\#1. Immunoblot analyses confirmed the resistance of both FLAG-Sept14^R^ and FLAG-Sept14ΔCC^R^ to Sept14-siRNA\#1 in COS7 cells ([Figure 6](#F6){ref-type="fig"}A). We next coelectroporated pCAG-EGFP and Sept14-siRNA\#1 together with pCAG-FLAG-Sept14^R^ or -FLAG-Sept14ΔCC^R^ into E14.5 cerebral cortices. Majority of EGFP/FLAG-Sept14^R^ double-positive cells were located in the superficial layer of CP at P2 ([Figure 6](#F6){ref-type="fig"}, B and C), suggesting that the positional defects by Sept14 knockdown were rescued by expression of exogenous Sept14. The expression of FLAG-Sept14ΔCC^R^, in contrast, was not able to rescue the phenotype induced by knockdown of Sept14 ([Figure 6](#F6){ref-type="fig"}, B and C), suggesting an essential role of the coiled-coil domain of Sept14. To further confirm the importance of the coiled-coil domain, we coelectroporated pCAG-EGFP with control pCAG vector or pCAG-FLAG-Sept14CC, which potentially exerts a dominant-negative effect. Consequently, EGFP/FLAG double-positive cells were more frequently observed in layer V to IV of CP and in IZ compared with control experiment ([Figure 7](#F7){ref-type="fig"}, A and B). Considering that the coiled-coil region of Sept14 is responsible for interaction with Sept4 ([Figure 4](#F4){ref-type="fig"}F), these results suggest that Sept14 is involved in neuronal migration via interaction with Sept4.

![Rescue of Sept14-siRNA--induced migration defect. (A) COS7 cells were cotransfected with Sept14-siRNA\#1 together with FLAG-Sept14, FLAG-Sept14^R^, FLAG-Sept14ΔCC, or FLAG-Sept14ΔCC^R^. After 72 h, cells were lysed and subjected to immunoblotting with anti-FLAG or anti-β-tubulin. (B) siRNA, pCAG-EGFP, and FLAG-tagged Sept14 mutants were coelectroporated into cerebral cortices in the indicated combinations at E14.5, followed by fixation at P2. Coronal sections were prepared and immunostained with anti-GFP (green) and anti-FLAG (red). Dotted lines represent pial and ventricular surfaces. Note that immunoreactivity of FLAG in the marginal zone and pial surface is artificial background. Bars, 100 μm. (C) Quantification of the distribution of EGFP-positive cells (cotransfection of siRNA, EGFP and empty vectors) or EGFP/FLAG double-positive cells (cotransfection of siRNA, EGFP, and FLAG-Sept14^R^ or FLAG-Sept14ΔCC^R^ vectors) in distinct parts of the cerebral cortex (layer II--IV, layer V--VI, IZ, and SVZ/VZ) for each experimental condition. Error bars indicate SD. \*\*p \< 0.01 and \*p \< 0.05, percentage of cells in each region.](zmk0081094200006){#F6}

![Impaired neuronal distribution by the expression of the coiled-coil domain of Sept14. (A) pCAG-EGFP and -FLAG-Sept14CC were coelectroporated into cerebral cortices at E14.5, followed by fixation at P2. Coronal sections were prepared and immunostained with anti-GFP (green) and anti-FLAG (red). Dotted lines represent pial and ventricular surfaces. Bar, 100 μm. (B) Quantification of the distribution of EGFP-positive cells (cotransfection of EGFP and empty vectors) or EGFP/FLAG double-positive cells (cotransfection of EGFP and FLAG-Sept14CC vectors) in distinct parts of the cerebral cortex (layer II--IV, layer V--VI, IZ, and SVZ/VZ) for each experimental condition. Error bars indicate SD. \*p \< 0.01, percentage of cells in each region relative to the corresponding values with control condition.](zmk0081094200007){#F7}

Involvement of Sept4 and Sept14 in Leading Process Formation
------------------------------------------------------------

Newborn cortical neurons generated from VZ primarily exhibit multipolar shapes in the lower part of IZ. The neurons then transform into a bipolar shape with a leading process in the upper part of IZ and migrate into CP toward pial surface ([@B61]; [@B45]). We next examined whether Sept14 and Sept4 are involved in the morphogenesis of migrating neurons. pCAG-EGFP were coelectroporated with control siRNA, Sept14-siRNA\#1, or Sept4siRNA\#1 at E14.5, and the morphology of migrating neurons in the lower CP were observed at E17.5. The distribution of EGFP-positive cells in cerebral cortex was much less different at this stage among all experimental conditions (data not shown). Sept14-siRNA\#1-- or Sept4-siRNA\#1--transfected bipolar cells in the lower CP exhibited shorter leading processes, compared with control siRNA-transfected cells ([Figure 8](#F8){ref-type="fig"}, A--D). In contrast, the morphology of multipolar cells in IZ was not affected by the transfection of Sept14-siRNA\#1 or Sept4-siRNA\#1 (data not shown). These results suggest that Sept14 and Sept4 are involved in leading process formation in migrating neurons.

![Roles of Sept14 and Sept4 in the leading process formation. (A--C) pCAG-EGFP was electroporated with control siRNA (A), Sept14-siRNA\#1 (B), or Sept4-siRNA\#1 (C) into cerebral cortices at E14.5, followed by fixation at E17.5. Coronal sections were prepared and immunostained with anti-GFP. Five representative images of migrating neurons in the lower CP in each experimental condition were shown. Bars, 20 μm. (D) Quantification of the length of the leading process. Numbers of cells used for each calculation are \>50. Error bars indicate SD. \*p \< 0.01.](zmk0081094200008){#F8}

We further examined the roles of Sept14 and Sept4 in process formation by using primary cultured hippocampal neurons, which exhibit highly polarized morphology ([@B8]). Both Sept14 and Sept4 distributed throughout soma, axon, and dendrite (Supplemental Figure 5). Transfection of Sept14-siRNA\#1 or Sept4-siRNA\#1 resulted in the reduction of primary axon length and total length of dendrites ([Figure 9](#F9){ref-type="fig"}, A--C). The number of primary axons, in contrast, were not affected by the knockdown of Sept14 or Sept4 ([Figure 9](#F9){ref-type="fig"}D). The observed phenotypes by knockdown were rescued by the coexpression of siRNA-resistant form of Sept14 (Sept14^R^) or Sept4 (Sept4^R^) (Supplemental Figure 6). We also examined whether Sept14 depletion affect the distribution of Sept4. Transfection of Sept14-siRNA\#1 or Sept14-siRNA\#2 did not alter the cytoplasmic distribution of endogenous Sept4 (Supplemental Figure 7). These results suggest that Sept14 and Sept4 are involved in process formation in neuronal cells, rather than cell autonomous polarity formation.

![Involvement of Sept14 and Sept4 in the process formation in primary cultured hippocampal neurons. (A) Dissociated neurons were obtained from E17.5 mouse, followed by cotransfection of pCAG-EGFP with control siRNA, Sept14-siRNA\#1, or Sept4-siRNA\#1. After 72 h, cells were fixed and immunostained with anti-GFP (green) and anti-tau-1 (red). Bars, 50 μm. (B--D) Quantifications of the length of primary axon (B), total length of primary dendrites (C), and the number of primary axon per cell (D). Numbers of cells used for each calculation are \>50. Error bars indicate SD. \*p \< 0.01.](zmk0081094200009){#F9}

DISCUSSION
==========

To date, the expression profiles of mammalian septins in various tissues have been widely reported. Some septins are predominantly distributed in neuronal tissues, whereas others are ubiquitously expressed ([@B32]; [@B69]; [@B62]; [@B27]). Human SEPT14 has been reported to be specifically expressed in testis, based on Northern blotting and RT-PCR analyses ([@B50]). In this study, we detected expression of mouse Sept14 in developing central nervous tissues and testis by immunoblotting ([Figure 1](#F1){ref-type="fig"}, A and B), RT-PCR ([Figure 1](#F1){ref-type="fig"}C), immunohistochemistry ([Figure 1](#F1){ref-type="fig"}D), and immunocytochemistry (Supplemental Figure 1). Because the results obtained are consistent with each other and two siRNAs against distinct regions of mouse *Sept14* effectively silenced endogenous Sept14 in neurons ([Figures 2](#F2){ref-type="fig"}B and Supplemental Figure 1), we conclude that Sept14 is expressed in developing brain, at least in mice.

It has so far been reported that expression of several septins is developmentally regulated in cerebral cortex; the protein levels of Sept2, Sept5, Sept6, Sept7, and Sept8 gradually increase at late embryonic stage through early postnatal days ([@B62]; [@B27]). In this study, we showed that expression of mouse Sept14 in cerebral cortex is also regulated in the embryonic stage. Although the expression was not detected before E13.5 ([Figure 1](#F1){ref-type="fig"}B; data not shown), a dramatic increase was observed in CP around E15.5 and thereafter ([Figure 1](#F1){ref-type="fig"}, B--D; data not shown). It is thus possible that Sept14 is not only involved in neuronal migration but also in neuronal maturation, including spine morphogenesis and synaptic contact, like other septins ([@B62]; [@B67]; [@B36]).

Directed migration of neurons during corticogenesis is an essential event for brain development. In humans, disruption of the ordered neuronal migration leads to cortical malformations, including lissencephaly and periventricular heterotopia. In this study, we report that Sept14 and Sept4 are involved in neuronal migration and morphogenesis during corticogenesis. Although previous studies suggested the requirement of septins in migration of nonneuronal cells ([@B14]; [@B22]), the underlying molecular mechanisms still remain to be elucidated. It is well accepted that directed cell migration and morphological changes are tightly associated with each other and executed by a coordinated regulation of microtubules and actin filaments ([@B11]). Indeed, several molecules concerned in microtubule dynamics, such as Doublecortin, LIS1, microtubule-associated protein 1B, c-Jun NH~2~-terminal kinase (JNK), and focal adhesion kinase, have been reported to play important roles in neuronal migration ([@B9]; [@B21]; [@B63]; [@B28]; [@B68]). Regulators of actin cytoskeleton, such as Filamin A, Myosin II, and Cofilin, are also suggested to be involved in neuronal migration ([@B15]; [@B53]; [@B30]). Given that mammalian septins interact, if not directly, with F-actin as well as microtubules and probably modulate their dynamics in vivo ([@B1]; [@B58]; [@B41]; [@B35]), it is possible that Sept14 and Sept4 are involved in neuronal migration by modulating functions of cytoskeleton-regulating proteins and/or cytoskeleton itself.

It should be noted that the cytoskeleton-related molecules as mentioned above also play important roles in the regulation of neuronal cell morphology ([@B2]). In this study, we show that knockdown of Sept14 or Sept4 resulted in shortening of the leading process of migrating cortical neurons ([Figure 8](#F8){ref-type="fig"}, A--D) and defective extension of axon and dendrite in cultured hippocampal neurons ([Figure 9](#F9){ref-type="fig"}, A--C). It is reported that newborn cortical neurons transfected with a dominant-negative version of Rac1 does not form leading processes and that neurons transfected with a dominant-negative version of JNK exhibit short and twisted leading processes ([@B28]). Because migration defect was consequently observed in both cases, neuronal migration is likely to be related to cell morphology and abnormal cell shape may at least partly contribute to migration defect. Although the molecular basis linking the leading process formation to neuronal migration still remains to be elucidated, findings obtained in the present study may support the hypothesis that proper formation of leading process is crucial to coordinated neuronal migration.

Recently, structure models of Sept2 dimer and Sept2/6/7 complex have proposed ([@B56]). Based on their x-ray crystallography and electron microscopic observation, these septins have two alternative interacting interfaces, named G-dimer or NC-dimer, and C-terminal coiled-coil regions of Sept2, Sept6, and Sept7 are not likely to be required for their oligomeric complex formation. Conversely, we here propose the importance of the C-terminal coiled-coil region of Sept14 for the interaction with Sept4, at least in our experimental conditions. Because observations obtained in this study could not be simply explained by the G- or NC-dimer model, another mode of interaction, such as coiled-coil-mediated association, might exist in septin oligomerization. It is also possible that Sept14 and Sept4 form a G- or NC-dimer-like complex, although the affinity of coiled-coil-mediated interaction may be much higher in certain physiological conditions. Crystallography and electron microscopic analyses will shed light on the mode of Sept14--Sept4 interaction.

It is notable that Sept4-dificient mice did not show any morphological alteration in cerebral cortex ([@B23]; [@B24]). Alternatively, we here observed that acute knockdown of Sept4 as well as Sept14 is involved in cortical neuronal migration ([Figure 5](#F5){ref-type="fig"}, C and D). In this context, conditional and acute knockdown by the combination of in utero electroporation and RNAi is suggested to circumvent the compensatory effects of general gene-knockout approaches. Indeed, Doublecortin- or P27^Kip1^-deficient mice exhibited no obvious morphological alteration in cerebral cortex ([@B12]; [@B34]; [@B43]; [@B7]), whereas acute knockdown of these genes by in utero electroporation resulted in defective neuronal migration ([@B3]; [@B30]). Considering that many septin molecules including Sept14 are expressed in developing cerebral cortex ([Figure 1](#F1){ref-type="fig"}, B--D; [@B27]), it is possible that these septins may partially compensate for the function of Sept4 in migrating neurons of Sept4-deficient mice.

It was recently reported that the expression of several septins is up-regulated in the prefrontal cortex of schizophrenic and bipolar patients ([@B49]). Intriguingly, Sept5-dificient mice also showed a schizophrenia-related phenotype ([@B59]). It is now widely accepted that the pathogenesis of schizophrenia is related to cortical development, especially of the prefrontal area ([@B66]). Thus, it is tempting to speculate that defective cortical development induced by the dysfunction of Sept14, Sept4, or other septins may contribute to the onset and/or progress of schizophrenia, although intensive studies are needed to clarify the molecular mechanisms linking pathophysiology of the disease and septins.
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CP

:   cortical plate

IZ

:   intermediate zone

SVZ

:   subventricular zone

VZ

:   ventricular zone.
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